Off-label use of medicines is bad medicine flying the flag of clinical freedom

International Journal of Obstetric Anesthesia

Volumn 18, Issue 3, 2009, Pages 249-250

  Sneyd, J R ^a  

^a PENINSULA MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

REMIFENTANIL;

ARTICLE; CLINICAL PRACTICE; EVIDENCE BASED MEDICINE; OBSTETRIC ANALGESIA; OFF LABEL DRUG USE; PHYSICIAN ATTITUDE;

ANESTHETICS, INTRAVENOUS; DRUG LABELING; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; PIPERIDINES; PREGNANCY;

EID: 67649494328     PISSN: 0959289X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijoa.2009.03.008     Document Type: Article

References (10)

1. Eypasch E., Lefering R., Kum C.K., and Troidl H. Probability of adverse events that have not yet occurred: a statistical reminder. BMJ 311 (1995) 619-620
2. Maynard A. Translating evidence into practice: why is it so difficult?. Public Money & Management 27 (2007) 251-256
3. Howell CJ. Epidural versus non-epidural analgesia for pain relief in labour. Cochrane database of systematic reviews (Online). 2000.
4. Parker M. False dichotomies: EBM, clinical freedom, and the art of medicine. J Med Ethics 31 (2005) 23-30
5. Hill D. Remifentanil patient-controlled analgesia should be routinely available for use in labour: Proposer. Int J Obstet Anesth 17 (2008) 336-339
6. Van de Velde M. Remifentanil patient-controlled analgesia should be routinely available for use in labour: Opposer. Int J Obstet Anesth 17 (2008) 339-341
7. http://emc.medicines.org.uk/document.aspx?documentId=14766 (accessed Date 2005).
8. http://emc.medicines.org.uk/medicine/14337/XPIL/Ultiva+Injection/ (accessed Date 2008).
9. http://emc.medicines.org.uk/medicine/8375/XPIL/Diprivan+1%25/ (accessed Date 2008).
10. http://emc.medicines.org.uk/medicine/2275/SPC/Diprivan+1%25/ (accessed Date 2008).